ArticleJournal of pharmaceutical policy and practice2025
Inter-rater reliability and validity of supervision performance assessment and recognition (SPARS) indicators to assess medicines management in public health facilities in Nepal.
Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Supervision, performance assessment, and recognition strategy (SPARS) - a multipronged strategy to strengthen medicines management in Nepal: pilot study methods and baseline results.Journal of pharmaceutical policy and practice · 2025Article
- Costs of the Supervision, Performance Assessment and Recognition Strategy (SPARS) for improving medicines management in Nepal.Journal of pharmaceutical policy and practice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nepal's Ministry of Health and Population piloted the Supervision, Performance Assessment, and Recognition Strategy (SPARS), a multipronged strategy to improve medicines management practices in health facilities. Medicines management supervisors (MMS) periodically assess facility performance using 25 indicators grouped into 5 domains - prescribing, dispensing, ordering and reporting quality and stock and storage management - and provide targeted on-the-job coaching. This study aimed to determine inter-rater reliability (IRR) and validity for SPARS indicators in Nepali context. Methods: We assessed IRR and validity scores with three rater teams assessing medicines management in six public health posts. Each team of three MMS and one technical advisor evaluated two facilities, resulting in 24 total assessments. We calculated the mean and median validity and IRR scores for SPARS overall, and by domain and indicator. Acceptable scores were mean validity and IRR scores ≥75%, moderately acceptable were 50-75%, and unacceptable were <50%. Results: The mean overall IRR (60%) and validity (74%) of all 25 SPARS indicators were significantly different ( Conclusions: This study demonstrated that the SPARS indicators produce moderately accurate findings. Validity was significantly higher than IRR and both need improvement, especially for complex indicators. As such, future SPARS implementation should endeavour to include validity and IRR assessments to help improve the indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.